Cormorant Capital
North America, New York, United States, New York
Description
Cormorant Capital facilitates the growth of real estate-operator and owner clients by co-investing in select transactions.
Investor Profile
Cormorant Capital has backed more than 13 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 8 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series D rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, China.
- Strong thematic focus on Biotechnology, Health Care, Medical.
Stage Focus
- Series B (31%)
- Series C (23%)
- Series D (15%)
- Series Unknown (15%)
- Private Equity (8%)
- Series A (8%)
Country Focus
- United States (85%)
- Switzerland (8%)
- China (8%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Pharmaceutical
- Life Science
- Therapeutics
- Health Diagnostics
- Personal Health
- Robotics
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Cormorant Capital frequently co-invest with?
What are some of recent deals done by Cormorant Capital?
Find More Investors Like Cormorant Capital
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides









